ChemomAb Competitors and Similar CompaniesClear all
ChemomAb's competitors and similar companies include Autolus.
 ChemomAb ChemomAb is a clinical stage biopharmaceutical company which develops therapeutic antibodies for the treatment of autoimmune and inflammatory diseases. |  Autolus Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products. | |
Founding Date | Founding Date 2010 | Founding Date 2014 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Tel Aviv-Yafo, IL HQ | Locations London, GB HQ London, GB |
Employees | Employees N/A | Employees 647 |
Valuation ($) | Valuation ($) 28.1 m | Valuation ($) 1.2 b |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $75.4m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $86.6m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ($10.7m) (FY, 2025) |
Net income | Net income ($9m) (FY, 2025) | Net income ($287.5m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 15m | Total funding raised $ 281.7m |
For sources of this data, please see the company profile
View Company Profiles
Autolus
HQ
London, GB
Employees
647
Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products.
View company